Zobrazeno 1 - 10
of 524
pro vyhledávání: '"William Strauss"'
Autor:
Jesse Gerb, William Strauss, Richard Derman, Vanessa Short, Ben Mendelson, Huzefa Bahrain, Michael Auerbach
Publikováno v:
Therapeutic Advances in Hematology, Vol 12 (2021)
Introduction: A litany of recent evidence supports the morbidity of intra-natal iron-deficiency anemia and its prodrome, iron deficiency. Oral iron administered during second and third trimesters does not get to the developing fetus if the mother is
Externí odkaz:
https://doaj.org/article/021f02cc30a64cd4909958763bb300cb
Publikováno v:
Journal of the American College of Cardiology. 81:425-427
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aba327efd3066e12d4163c41ee7b9982
https://doi.org/10.1016/j.jacc.2022.12.009
https://doi.org/10.1016/j.jacc.2022.12.009
Autor:
Darko Pucar, H William Strauss
Publikováno v:
Journal of Nuclear Cardiology. 29:535-539
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fd83ad0f03222dbcb9295e6fdc6f9b2
https://doi.org/10.1007/s12350-021-02718-3
https://doi.org/10.1007/s12350-021-02718-3
Publikováno v:
Seminars in nuclear medicine.
Atherosclerotic plaques progress as a result of inflammation. Both invasive and noninvasive imaging techniques have been developed to identify and characterize plaque as vulnerable (more likely to rupture and cause a clinical event). Imaging techniqu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5624f6e69aa4c1eb5dce2be7bcfefa82
https://pubmed.ncbi.nlm.nih.gov/36333157
https://pubmed.ncbi.nlm.nih.gov/36333157
Autor:
H. William Strauss
Publikováno v:
Journal of Nuclear Medicine. 61:23S-29S
> We are not going to be the first to this party, but we are going to be the best. > > —Steve Jobs The initial tracer used to study bone metabolism ([1][1],[2][2]) was the artificially produced radionuclide 32P. The tracer, made as described in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2067fbe17b4279f616df07c36f2b8ce3
https://doi.org/10.2967/jnumed.120.249045
https://doi.org/10.2967/jnumed.120.249045
Autor:
Phillip D. Levy, Farhan Chaudhry, Jinhua Liu, Hideki Kawai, Peter S. Heeger, Jeffrey A. Mattis, Navneet Narula, Matthew K.M.Y. Adapoe, Andre L. Moreira, Aditya Shekhar, Yansui Li, Kipp W. Johnson, H. William Strauss, Jagat Narula, Koon Y. Pak, Julian K. Horwitz, Artiom Petrov
Publikováno v:
JACC: Cardiovascular Imaging. 13:1438-1441
About 5,400 heart transplantations are performed around the world annually. Survival in allograft recipients has improved substantially over the years with effective immunosuppressive therapy. However, acute cellular or antibody-mediated allograft re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4445c5207fa4b0e220312bb29d41492b
https://doi.org/10.1016/j.jcmg.2020.01.010
https://doi.org/10.1016/j.jcmg.2020.01.010
Autor:
H. William Strauss, Josef J. Fox
Publikováno v:
Nuclear Oncology ISBN: 9783319260679
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c28f4aa8ebafda7bce7b7a01cc2ba1c
https://doi.org/10.1007/978-3-031-05494-5_88
https://doi.org/10.1007/978-3-031-05494-5_88
Autor:
Josef J. Fox, H. William Strauss
Publikováno v:
Nuclear Oncology ISBN: 9783319260679
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72066ebdf0e76d3dad79b8ab06297035
https://doi.org/10.1007/978-3-319-26067-9_29-2
https://doi.org/10.1007/978-3-319-26067-9_29-2
Autor:
Kipp Johnson, Jagat Narula, Benjamin Glicksberg, Khader Shameer, Farhan Chaudhry, Alexandre Yahi, Nayaab Khan, Letizia Amadori, Chayakrit Krittanawong, Ben Readhead, Ross Hagan, Christine Becker, Fayzan Chaudhry, Aparna Divaraniya, Milo Smith, Usman Baber, Li Li, Benjamin McCauley, Girish Nadkarni, Koon Yan Pak, Brian Gray, Deepak Kaji, Bethany Percha, Yuliya Vengrenyuk, Javed Suleman, Nicholas Tatonetti, Atul Butte, Artiom Petrov, Eloisa Arbustini, Chiara Giannarelli, Navneet Narula, William Strauss, Joel Dudley, Annapoorna Kini
Background. Current lipid-lowering drugs often leave significant residual risk for adverse outcomes. Identification of previously approved drugs for new indications, drug repurposing, may provide a cost effective alternative to de novo drug developin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ad2561ef45f95e914c21259220acf6a
https://doi.org/10.21203/rs.3.rs-567817/v1
https://doi.org/10.21203/rs.3.rs-567817/v1